IL4, interleukin 4, 3565

N. diseases: 996; N. variants: 23
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Insulin-Dependent
0.300 AlteredExpression disease BEFREE Determination of mRNA expression for IFN-gamma and IL-4 in lymphocytes from children with IDDM by RT-PCR technique. 9699087 1998
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE Mice inoculated with the IL-4 expressing CVB3 chimeric strain were better protected from T1D onset than were mock-infected control mice despite intraislet viral replication. 15518817 2004
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE Whereas a biased Th1 to Th2 cytokine profile has been suggested to underlie the pathogenesis of IMD in both species, we found defective production of IFN-gamma in our patients after in vitro stimulation of their PBMCs by phorbol-myristate acetate and ionomycin and both IFN-gamma and IL-4 deficiencies in V(alpha)24(+) NK T-enriched cells. 11781358 2002
Diabetes Mellitus, Insulin-Dependent
0.300 AlteredExpression disease BEFREE A significant increase in the levels of interleukin-4 (IL-4), IL-10, and transforming growth factor-β, and a decrease in the levels of IL-17 and interferon-γ in concordance with the significant increase in the Treg cell ratio in splenic MNCs (P < 0.05) was shown in T1DM mice treated with AD-MSC's exosomes as compared to T1DM untreated mice. 30074271 2018
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE Individual SNPs and SNP haplotypes in IL4R, which encodes the alpha-chain of the IL4 and IL13 receptors, have been associated with T1D in some reports, but not in others. 19956098 2009
Diabetes Mellitus, Insulin-Dependent
0.300 AlteredExpression disease BEFREE Markedly elevated levels of serum IL-4 were reported previously in 50% of a small group of type 1 diabetes nonprogessors. 10393957 1999
Diabetes Mellitus, Insulin-Dependent
0.300 GeneticVariation disease BEFREE Gene-gene interaction, albeit only marginally significant, has recently been reported for the interleukin-4 and interleukin-13 genes (IL4 and IL13) with the interleukin-4 receptor A gene (IL4RA), contributing to the susceptibility of type 1 diabetes (T1D). 15660293 2005
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE To test the feasibility of muscle-directed gene therapy to prevent type 1 diabetes, we developed recombinant adeno-associated virus (rAAV) vectors containing murine cDNAs for immunomodulatory cytokines IL-4 or IL-10. 11717448 2001
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE Our data constitute the first functional study of AS in T1D, which may provide a new rationale for future translational studies.-Li, Z., Shi, X., Liu, J., Shao, F., Huang, G., Zhou, Z., Zheng, P. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells. 30916998 2019
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE The delivery of transgenes capable of interfering with antigenic recognition and/or cell death [e.g., Fas ligand (FasL), Bcl-2, Bcl-XL] as well as imparting tolerance/immunoregulation [e.g., interleukin(IL)-4, IL-10, transforming growth factor (TGF)-beta], or cytoprotection [e.g., heme oxygenase-1 (HO-1), catalase, manganese superoxide dismutase (MnSOD)] may prevent recurrent type 1 diabetes in islet transplantation and offer a promising form of immunotherapy. 11899074 2001
Diabetes Mellitus, Insulin-Dependent
0.300 AlteredExpression disease BEFREE In particular, the production of IL-1beta and IL-4 during the non-diabetic period together with the lack of enhancement of CD4 and CD25, indicating selective recruitment of activated T cells, may explain the failure of anti-diabetic treatments in this animal model of type 1 diabetes. 16972262 2006
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE IL4 and IL4Ralpha genes are not linked or associated with type 1 diabetes. 10674354 2000
Diabetes Mellitus, Insulin-Dependent
0.300 GeneticVariation disease BEFREE Genes involved in the IL-4 regulatory pathway (IL-4, IL-4R, IL-13) may confer susceptibility or protection to type 1 diabetes depending on individual SNPs or specific haplotypes. 16046318 2005
Diabetes Mellitus, Insulin-Dependent
0.300 AlteredExpression disease BEFREE Following STZ treatment to induce T1D, NLRP3-deficient mice also exhibited an increase in myeloid-derived suppressor cell and mast cell numbers in the PLNs along with a significant increase in IL-6, IL-10, and IL-4 expression in the pancreatic tissue. 28289409 2017
Diabetes Mellitus, Insulin-Dependent
0.300 GeneticVariation disease BEFREE Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety. 11754351 2002
Diabetes Mellitus, Insulin-Dependent
0.300 GeneticVariation disease BEFREE The -590C/T IL4 SNP was not found associated with T1D or RA when individual analyses were performed. 18064451 2008
Diabetes Mellitus, Insulin-Dependent
0.300 GeneticVariation disease BEFREE Furthermore, IL-4 T allele was statistically associated with T1D patients compared to control group (OR = 2.24, p < 0.001). 29257900 2018
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE In order to study cytokine production profile (IFN-gamma, IL-4 and TNF-alpha) and TCRBV-gene usage of peripheral autoreactive T cells from IDDM patients, we have generated antigen-specific T cell lines with either tetanus toxoid, insulinoma membranes or a single beta-cell protein, recombinant ICA69, which has been shown to be a target of both autoantibodies and T cells in IDDM. 9451599 1997
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE To investigate the transcriptional consequences of T cell receptor activation in human Valpha24JalphaQ T cell clones, DNA microarrays were used to quantitate changes in mRNA levels after anti-CD3 stimulation of clones derived from identical twins discordant for type 1 diabetes and IL-4 secretion. 10840051 2000
Diabetes Mellitus, Insulin-Dependent
0.300 AlteredExpression disease BEFREE Using transgenic plants expressing IL-4 and GAD65 may be a novel clinical approach to the prevention of human type 1 diabetes by oral tolerance. 15056761 2004
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE Sumoylation of c-Maf is increased in NOD CD4 cells as compared with CD4 cells from diabetes-resistant B10.D2 mice, suggesting that increased c-Maf sumoylation contributes to immune deviation in T1D by reducing c-Maf access to and transactivation of the IL-4 gene. 19553542 2009
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE Our study aimed to analyse the effectiveness of the M2 differentiation process in vitro (achieved by IL-4 stimulation) and its relationship to the stage of type 1 diabetes mellitus (DM1) in juvenile patients. 30820875 2019
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE Patients with IDDM of longer duration (>2 yr) showed a wide range of IL-4 responses and their mean IL-4 response was lower than the controls; however, the difference was not statistically significant. 8906850 1996
Diabetes Mellitus, Insulin-Dependent
0.300 AlteredExpression disease BEFREE The present results suggested that anti‑CD20 and IL‑10 treatment in NOD mice can modulate the immune functions by upregulating GATA‑3 and IL‑4 expression as well as downregulating T‑bet and IFN‑γ expression, which are involved in the pathogenesis of T1D. 28765956 2017
Diabetes Mellitus, Insulin-Dependent
0.300 Biomarker disease BEFREE A number of genes have been associated with type 1 diabetes in humans, including the human leukocyte antigen region, the insulin variable number tandem repeat, PTPN22, CTLA4, IL-4, and IL-13. 17611256 2007